Laser scleral microporation: Unique method to treat presbyopia goes back to basics
Laser scleral microporation is a unique therapeutic solution for presbyopia that goes back to basics, rejuvenating the eye and restoring the natural dynamic mechanism of accommodation and disaccommodation.
“Nature frequently develops dynamic processes, which work well for most individuals for the first 40 or 50 years of life but then, because of changes in the intrinsic properties of some or all the various components involved, begin to break down,” John Marshall, PhD, FRCPath, FMedSci, told Healio.
Explore More Articles
Ace Vision Group Names Val Kolesnitchenko, MD, as Chief Scientific Officer
Ace Vision Group announced that it has named Val Kolesnitchenko, MD, as Chief Scientific Officer. Dr. Kolesnitchenko has served in leadership roles for three decades in clinical ophthalmology practice and industry. Most recently, he held the position of Executive Director of Global Scientific Affairs at Bausch + Lomb, overseeing the medical and clinical development of the …
read moreData show higher patient expectations for presbyopia laser therapy among women
MARCO ISLAND, Fla. — In this Healio Video Perspective, AnnMarie Hipsley, DPT, PhD, discusses data that compared the patient-reported satisfaction levels of women and men with presbyopia after laser scleral microporation therapy. “Interestingly enough, we had more women than men, about twice as many women in the study, and women were more demanding with their satisfaction than men,” …
read moreAce Vision Group Names David Lin, MD, as Chief Medical Advisor
Dr. Lin’s pioneering expertise in refractive lasers, algorithms and the medical device industry will help drive Ace Vision Group’s device development. BOSTON, Oct. 18, 2024 /PRNewswire/ — Ace Vision Group, Inc., an emerging medical device company at the forefront of pioneering rejuvenation therapy for the aging eye, today announced the appointment of David Lin, MD as Chief Medical Advisor (CMA). Dr. Lin …
read more